Yayınlar & Eserler

Yayın Ağı
Makaleler 45
Tümü (45)
SCI-E, SSCI, AHCI (35)
SCI-E, SSCI, AHCI, ESCI (44)
ESCI (9)
Scopus (44)
TRDizin (7)

1. Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities

Wang T., Askan G., Ozcan K., Rana S., Zehir A., Bhanot U. K., et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE , cilt.147, sa.12, ss.1390-1401, 2023 (SCI-Expanded, Scopus)

2. Response to letter to the editor

OKCU O., Öztürk Ç., Şen B., Ayazoğlu S., Güvendi G. F., Öztürk S. D., et al.
Annals of Diagnostic Pathology , cilt.66, 2023 (SCI-Expanded, Scopus)

3. The prognostic significance of non-lymphoid immune cells of the tumor microenvironment, including neutrophils, eosinophils, and mast cells in breast carcinomas

OKCU O., Ozturk C., Sen B., Ayazoglu M. S., FINDIK GÜVENDİ G., DUMAN ÖZTÜRK S., et al.
ANNALS OF DIAGNOSTIC PATHOLOGY , cilt.65, 2023 (SCI-Expanded, Scopus)

4. Does Apoptotic Index Predict the Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma?

OKCU O., ÖZTÜRK S. D., ŞEN B., BEDİR R., ÖZTÜRK Ç., ASKAN G.
Medeniyet Medical Journal , cilt.38, sa.1, ss.1-7, 2023 (Scopus, TRDizin)

5. Tumor Budding is an Independent Prognostic Factor to Predict Overall Survival in Endometrial Endometrioid Carcinoma: A Retrospective Study

OKCU O., Sen B., Askan G., Ozturk C., Ozturk S. D., BEDİR R.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY , cilt.31, sa.1, ss.26-37, 2023 (SCI-Expanded, Scopus)

6. Predicting response to neoadjuvant therapy with glucose transporter-1 in breast cancer

Ozturk S. D., Ozturk C., OKCU O., Askan G., Sen B., BEDİR R.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , cilt.69, sa.3, ss.440-446, 2023 (SCI-Expanded, Scopus)

7. High Tumor Infiltrating Lymphocytes Are Associated with Overall Survival and Good Prognostic Parameters in Endometrial Endometrioid Carcinoma Patients

Ozturk C., Askan G., Ozturk S. D., OKCU O., Sen B., BEDİR R.
TURKISH JOURNAL OF PATHOLOGY , cilt.39, sa.1, ss.75-82, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

8. Prognositc Significance of Microcystic Elongated and Fragmanted (MELF) Myometrial Invasion Pattern: A Retrospective Study

OKCU O., ASKAN G., ŞEN B., ÖZTÜRK Ç., ÖZTÜRK S. D., GÜVEND G. F.
Medeniyet Medical Journal , cilt.37, sa.3, ss.121-219, 2022 (ESCI, Scopus, TRDizin)

9. Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer

Joshi S., Gomes E. D., Wang T., Corben A., Taldone T., Gandu S., et al.
COMMUNICATIONS BIOLOGY , cilt.4, sa.1, 2021 (SCI-Expanded, Scopus)

10. Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall

Askan G., Basturk O.
TURKISH JOURNAL OF PATHOLOGY , cilt.37, sa.2, ss.115-120, 2021 (ESCI, Scopus, TRDizin)

11. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

Singh K., Lin J., Lecomte N., Mohan P., Gokce A., Sanghvi V. R., et al.
CANCER RESEARCH , cilt.81, sa.8, ss.2002-2014, 2021 (SCI-Expanded, Scopus)

12. Transarterial Embolization of Liver Cancer in a Transgenic Pig Model

Michel A. O., Bendet A., Cheleuitte-Nieves C., Yarmohammadi H., Nurili F., Monette S., et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY , cilt.32, sa.4, ss.510-520, 2021 (SCI-Expanded, Scopus)

13. The origins and consequences of UPF1 variants in pancreatic adenosquamous carcinoma

Polaski J. T., Udy D. B., Escobar-Hoyos L. F., Askan G., Leach S. D., Ventura A., et al.
ELIFE , cilt.10, 2021 (SCI-Expanded, Scopus)

14. Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma

Grbovic-Huezo O., Pitter K. L., Lecomte N., Saglimbeni J., AŞKAN G., Holm M., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.117, sa.48, ss.30670-30678, 2020 (SCI-Expanded, Scopus)

15. Induction and characterization of pancreatic cancer in a transgenic pig model

Boas F. E., Nurili F., Bendet A., Cheleuitte-Nieves C., Basturk O., AŞKAN G., et al.
PLOS ONE , cilt.15, sa.9, 2020 (SCI-Expanded, Scopus)

16. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer

Escobar-Hoyos L. F., Penson A., Kannan R., Cho H., Pan C., Singh R. K., et al.
CANCER CELL , cilt.38, sa.2, ss.198-219, 2020 (SCI-Expanded, Scopus)

17. Smooth muscle tumors of the gastrointestinal tract: an analysis of prognostic features in 407 cases

Alpert L., Al-Sabti R., Graham R. P., Pai R. K., Gonzalez R. S., Zhang X., et al.
MODERN PATHOLOGY , cilt.33, sa.7, ss.1410-1419, 2020 (SCI-Expanded, Scopus)

18. Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms

Harrington K. A., Williams T. L., Lawrence S. A., Chakraborty J., Al Efishat M. A., Attiyeh M. A., et al.
JOURNAL OF MEDICAL IMAGING , cilt.7, sa.3, 2020 (ESCI, Scopus)

19. DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma

Vyas M., Hechtman J. F., Zhang Y., Benayed R., Yavas A., Askan G., et al.
MODERN PATHOLOGY , cilt.33, sa.4, ss.648-656, 2020 (SCI-Expanded, Scopus)

20. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity

Moral J. A., Leung J., Rojas L. A., Ruan J., Zhao J., Sethna Z., et al.
NATURE , cilt.579, sa.7797, ss.130-154, 2020 (SCI-Expanded, Scopus)

21. Sclerosing epithelioid mesenchymal neoplasm of the pancreas - a proposed new entity

Basturk O., Weigelt B., Adsay V., Benhamida J. K., Askan G., Wang L., et al.
MODERN PATHOLOGY , cilt.33, sa.3, ss.456-467, 2020 (SCI-Expanded, Scopus)

22. Precision medicine for metastatic colorectal cancer: an evolving era

Guler I., Askan G., Klostergaard J., Sahin I. H.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY , cilt.13, sa.10, ss.919-931, 2019 (SCI-Expanded, Scopus)

23. Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma

Wang T., Drill E., Vakiani E., Pak L. M., Boerner T., Askan G., et al.
HUMAN PATHOLOGY , cilt.91, ss.19-25, 2019 (SCI-Expanded, Scopus)

24. Clear Cell Sarcoma-Like Tumor of the Gastrointestinal Tract

Askan G., Kombak F. E., Seven I. E., Basturk O.
JOURNAL OF GASTROINTESTINAL CANCER , cilt.50, sa.3, ss.651-656, 2019 (ESCI, Scopus)

25. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma

Attiyeh M. A., Chakraborty J., McIntyre C. A., Kappagantula R., Chou Y., Askan G., et al.
ABDOMINAL RADIOLOGY , cilt.44, sa.9, ss.3148-3157, 2019 (SCI-Expanded, Scopus)

26. Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas

Wang T., Askan G., Adsay V., Allen P., Jarnagin W. R., Memis B., et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY , cilt.43, sa.5, ss.656-661, 2019 (SCI-Expanded, Scopus)

27. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations

Narayan R. R., Creasy J. M., Goldman D. A., Gonen M., Kandoth C., Kundra R., et al.
CANCER , cilt.125, sa.4, ss.575-585, 2019 (SCI-Expanded, Scopus)

28. Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

Lowery M. A., Wong W., Jordan E. J., Lee J. W., Kemel Y., Vijai J., et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , cilt.110, sa.10, 2018 (SCI-Expanded, Scopus)

29. Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns

Sigel C. S., Drill E., Zhou Y., Basturk O., Askan G., Pak L. M., et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY , cilt.42, sa.10, ss.1334-1345, 2018 (SCI-Expanded, Scopus) Creative Commons License

30. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

Tiriac H., Belleau P., Engle D. D., Plenker D., Deschenes A., Somerville T. D. D., et al.
CANCER DISCOVERY , cilt.8, sa.9, ss.1112-1129, 2018 (SCI-Expanded, Scopus)

31. Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer

Zheng J., Hernandez J. M., Doussot A., Bojmar L., Zambirinis C. P., Costa-Silva B., et al.
HPB , cilt.20, sa.7, ss.597-604, 2018 (SCI-Expanded, Scopus)

32. Dedifferentiated Liposarcoma of the Gastroesophageal Junction

Askan G., Bagci P., Hameed M., Basturk O.
TURKISH JOURNAL OF PATHOLOGY , cilt.34, sa.1, ss.104-107, 2018 (ESCI, Scopus, TRDizin)

33. A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms

Wang L., Basturk O., Wang J., Benayed R., Middha S., Zehir A., et al.
MODERN PATHOLOGY , cilt.31, sa.1, ss.132-140, 2018 (SCI-Expanded, Scopus)

34. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma

Basturk O., Berger M. F., Yamaguchi H., Adsay V., Askan G., Bhanot U. K., et al.
MODERN PATHOLOGY , cilt.30, sa.12, ss.1760-1772, 2017 (SCI-Expanded, Scopus)

35. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

Balachandran V. P., Luksza M., Zhao J. N., Makarov V., Moral J. A., Remark R., et al.
NATURE , cilt.551, sa.7681, ss.512-534, 2017 (SCI-Expanded, Scopus)

36. Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype

Lowery M. A., Jordan E. J., Basturk O., Ptashkin R. N., Zehir A., Berger M. F., et al.
CLINICAL CANCER RESEARCH , cilt.23, sa.20, ss.6094-6100, 2017 (SCI-Expanded, Scopus)

37. Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies

Creasy J. M., Goldman D. A., Gonen M., Dudeja V., Askan G., Basturk O., et al.
JOURNAL OF GASTROINTESTINAL SURGERY , cilt.21, sa.8, ss.1254-1261, 2017 (SCI-Expanded, Scopus)

38. Intraductal Neoplasms of the Pancreas: An Update

Askan G., Bagci P., Memis B., Basturk O.
TURKISH JOURNAL OF PATHOLOGY , cilt.33, sa.2, ss.87-102, 2017 (ESCI, Scopus, TRDizin) Creative Commons License

39. PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk

Sinha S., Fu Y., Grimont A., Ketcham M., Lafaro K., Saglimbeni J. A., et al.
CANCER RESEARCH , cilt.77, sa.8, ss.1868-1879, 2017 (SCI-Expanded, Scopus)

40. Intraductal Tubulopapillary Neoplasm of the Pancreas A Clinicopathologic and Immunohistochemical Analysis of 33 Cases

Basturk O., Adsay V., Askan G., Dhall D., Zamboni G., Shimizu M., et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY , cilt.41, sa.3, ss.313-325, 2017 (SCI-Expanded, Scopus)

41. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas

Basturk O., Chung S. M., Hruban R. H., Adsay N. V., Askan G., Iacobuzio-Donahue C., et al.
VIRCHOWS ARCHIV , cilt.469, sa.5, ss.523-532, 2016 (SCI-Expanded, Scopus)

42. Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency

Silva V. W. K., Askan G., Daniel T. D., Lowery M., Klimstra D. S., Abou-Alfa G. K., et al.
CHINESE CLINICAL ONCOLOGY , cilt.5, sa.5, 2016 (ESCI, Scopus)

43. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes

Basturk O., Tan M., Bhanot U., Allen P., Adsay V., Scott S. N., et al.
MODERN PATHOLOGY , cilt.29, sa.9, ss.1058-1069, 2016 (SCI-Expanded, Scopus)

44. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms A Potential Diagnostic Pitfall

Askan G., Deshpande V., Klimstra D. S., Adsay V., Sigel C., Shia J., et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY , cilt.146, sa.2, ss.163-169, 2016 (SCI-Expanded, Scopus)

45. Periductal Stromal Tumor of the Breast: A Case Report and Review of the Literature

Askan G., Aribal E., Ak G., KAYA H.
JOURNAL OF BREAST HEALTH , cilt.12, sa.3, ss.133-136, 2016 (ESCI, TRDizin)